Home
>
National Drug Code (NDC)
>
Lysteda
Lysteda - 55566-2100-2 - (Tranexamic Acid)
Drug Information of Lysteda
| Product NDC: | 55566-2100 |
| Proprietary Name: | Lysteda |
| Non Proprietary Name: | Tranexamic Acid |
| Active Ingredient(s): | 650 mg/1 & nbsp; Tranexamic Acid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lysteda
| Product NDC: | 55566-2100 |
| Labeler Name: | Ferring Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022430 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100517 |
Package Information of Lysteda
| Package NDC: | 55566-2100-2 |
| Package Description: | 1 BOTTLE in 1 CARTON (55566-2100-2) > 30 TABLET in 1 BOTTLE |
NDC Information of Lysteda
| NDC Code | 55566-2100-2 |
| Proprietary Name | Lysteda |
| Package Description | 1 BOTTLE in 1 CARTON (55566-2100-2) > 30 TABLET in 1 BOTTLE |
| Product NDC | 55566-2100 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tranexamic Acid |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100517 |
| Marketing Category Name | NDA |
| Labeler Name | Ferring Pharmaceuticals Inc. |
| Substance Name | TRANEXAMIC ACID |
| Strength Number | 650 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
